tiprankstipranks
Addex Therapeutics (CH:ADXN)
:ADXN
Switzerland Market
Want to see CH:ADXN full AI Analyst Report?

Addex Therapeutics (ADXN) Financial Statements

1 Followers

Addex Therapeutics Financial Overview

Addex Therapeutics's market cap is currently CHF4.86M. The company's EPS TTM is CHF-0.0552; its P/E ratio is -0.75; Addex Therapeutics is scheduled to report earnings on June 25, 2026, and the estimated EPS forecast is CHF―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Dec 22Dec 21
Income Statement
Total RevenueCHF 173.00KCHF 410.04KCHF 1.61MCHF 1.42MCHF 2.92M
Gross ProfitCHF 164.39KCHF -444.26KCHF -5.32MCHF -13.20MCHF -9.67M
Operating IncomeCHF -2.81MCHF -2.76MCHF -2.24MCHF -20.52MCHF -15.51M
EBITDACHF -2.81MCHF -4.65MCHF -10.26MCHF -20.43MCHF -14.94M
Net IncomeCHF -6.73MCHF 7.06MCHF -10.56MCHF -20.80MCHF -15.41M
Balance Sheet
Cash & Short-Term InvestmentsCHF 1.64MCHF 3.34MCHF 3.87MCHF 6.96MCHF 20.50M
Total AssetsCHF 6.36MCHF 10.67MCHF 4.64MCHF 8.28MCHF 22.54M
Total DebtCHF 34.69KCHF 41.99KCHF 344.34KCHF 373.13KCHF 482.01K
Net DebtCHF -1.60MCHF -3.30MCHF -3.52MCHF -6.58MCHF -20.00M
Total LiabilitiesCHF 1.60MCHF 1.00MCHF 3.50MCHF 3.37MCHF 5.61M
Stockholders' EquityCHF 4.76MCHF 9.67MCHF 1.15MCHF 4.91MCHF 16.93M
Cash Flow
Free Cash FlowCHF -2.17MCHF -5.37MCHF -8.00MCHF -16.44MCHF -14.74M
Operating Cash FlowCHF -2.17MCHF -5.37MCHF -7.99MCHF -16.44MCHF -14.71M
Investing Cash FlowCHF -680.69KCHF 4.65MCHF -6.84KCHF 2.97KCHF -30.31K
Financing Cash FlowCHF 1.19MCHF 104.97KCHF 5.26MCHF 3.10MCHF 16.40M
Currency in CHF

Addex Therapeutics Earnings and Revenue History

Addex Therapeutics Debt to Assets

Addex Therapeutics Cash Flow

Addex Therapeutics Forecast EPS vs Actual EPS